Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MYNZ Mainz Biomed B.V.

Market Closed 05-17 16:00:00 EDT

0.6799

+0.0379

+5.90%

盘后0.6750

-0.0049-0.72%

16:42 EDT

High0.7100	Low0.6200	Vol83.67K
Open0.6299	D1 Closing0.6420	Amplitude14.02%
Mkt Cap14.88M	Tradable Cap12.50M	Total Shares21.89M
T/O55.28K	T/O Rate0.45%	Tradable Shares18.39M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MYNZ","market":"US","secType":"STK","nameCN":"Mainz Biomed B.V.","latestPrice":0.6799,"timestamp":1715976000000,"preClose":0.642,"halted":0,"volume":83670,"hourTrading":{"tag":"盘后","latestPrice":0.675,"preClose":0.6799,"latestTime":"16:42 EDT","volume":201,"amount":135.7063,"timestamp":1715978548462},"delay":0,"floatShares":18389181,"shares":21886575,"eps":-1.618962,"marketStatus":"Market Closed","change":0.0379,"latestTime":"05-17 16:00:00 EDT","open":0.6299,"high":0.71,"low":0.62,"amount":55282.74110190001,"amplitude":0.140187,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.618962,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":7,"adr":0,"listingDate":1635998400000,"exchange":"NASDAQ","adjPreClose":0.642,"preHourTrading":{"tag":"盘前","latestPrice":0.6299,"preClose":0.646,"latestTime":"09:29 EDT","volume":5134,"amount":3230.8426287999996,"timestamp":1715952598415},"postHourTrading":{"tag":"盘后","latestPrice":0.675,"preClose":0.6799,"latestTime":"16:42 EDT","volume":201,"amount":135.7063,"timestamp":1715978548462},"volumeRatio":0.51698378503325},"requestUrl":"/m/hq/s/MYNZ/tweets","defaultTab":"tweets","newsList":[{"id":"2435099686","title":"Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2435099686","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2435099686?lang=en_us&edition=fundamental","pubTime":"2024-05-16 22:51","pubTimestamp":1715871096,"startTime":"0","endTime":"0","summary":"On Sunday, Pfizer  and AstraZeneca Plc  were among the pharmaceutical companies who announced they will be investinga total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose France” business summit.Together with the domestic Sanofi , Pfizer, AstraZeneca will together invest 1.87 billion which is more than$2 billionto expand their operations in the country.According to the French government, AbbVie commited to spend36 million euros or $39 million to add jobs at its aesthetic medicine facility in Annecy-Pringy while Novartis will invest 30 million euros or $32 million in the creation of a production unit for for a specific treatment of prostate cancer. Kenvue commited invest 10.7 million euros or $11.6 million in the country. By doing so, Kenvue will create 45 jobs. Also, Kenvue is to expand production of four products at its facility in Normandy.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/N3lWgy9q6rQND8Jp5QVXYw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/b4ddeefb7aa891b262c5698a36b75643","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/N3lWgy9q6rQND8Jp5QVXYw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/b4ddeefb7aa891b262c5698a36b75643"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-astrazeneca-sanofi-mainz-biomed-145136527.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433208093","title":"Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.","url":"https://stock-news.laohu8.com/highlight/detail?id=2433208093","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2433208093?lang=en_us&edition=fundamental","pubTime":"2024-05-07 12:01","pubTimestamp":1715054460,"startTime":"0","endTime":"0","summary":"The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity for advanced adenoma of 82%BERKELEY, Calif. and MAINZ, Germany, May  07, 2024 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/07/2876703/0/en/Mainz-Biomed-to-Present-Results-of-Colorectal-Cancer-Screening-Study-eAArly-DETECT-at-Digestive-Disease-Week-2024-in-Washington-D-C.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431897542","title":"mRNA Is Promising A Breakthrough In Fighting Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2431897542","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2431897542?lang=en_us&edition=fundamental","pubTime":"2024-04-30 00:02","pubTimestamp":1714406563,"startTime":"0","endTime":"0","summary":"Mainz Biomed N.V. to revolutionize colorectal cancerdiagnostics and prevention.CRC has been recognized as the second most lethal cancer both in the U.S. and Europe. However, it is also among the most preventable ones as early detection results insurvival rates above 90%.A company specialized in molecular genetics diagnostic, Mainz Biomed,whoseflagship product, ColoAlert, a CRC screening test already showed its ability to detect even pre-cancerous polyps known as advanced adenomas thanks to mRNA biomarkers,just announced significant findings from a pooled clinical study as its flagship project undergoes a pivotal FDA clinical study for U.S. regulatory approval.Mainz Biomedconducted this study to fine tune and evaluate novel mRNA biomarkersalong withproprietary AI algorithm for integration into pivotal FDA PMA clinical trial for its next-generation CRC screening tool.With the help of mRNA, promising new treatments have emerged.Since its beginnings, Moderna has leveraged the power of mach","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/STtqdx4fS_ngXH.X1tRm7w--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/b1db3fde5bb654dd2ee59b99c89419f0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/STtqdx4fS_ngXH.X1tRm7w--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/b1db3fde5bb654dd2ee59b99c89419f0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mrna-promising-breakthrough-fighting-cancer-160243290.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429395774","title":"Mainz Biomed Announces Upcoming Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2429395774","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2429395774?lang=en_us&edition=fundamental","pubTime":"2024-04-24 18:59","pubTimestamp":1713956344,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed N.V. has scheduled its annual general meeting for shareholders on May 31, 2024, at 14...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-announces-upcoming-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-announces-upcoming-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2428658236","title":"Mainz Biomed Secures New Funding Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2428658236","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2428658236?lang=en_us&edition=fundamental","pubTime":"2024-04-19 19:29","pubTimestamp":1713526173,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed B.V. enters into a supplemental agreement with YA II PN, LTD., involving a third Pre-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-secures-new-funding-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-secures-new-funding-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2426102224","title":"The Pharmaceutical Industry Finds Itself At A Historical Crossroads","url":"https://stock-news.laohu8.com/highlight/detail?id=2426102224","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2426102224?lang=en_us&edition=fundamental","pubTime":"2024-04-11 00:47","pubTimestamp":1712767671,"startTime":"0","endTime":"0","summary":"Johnson & Johnsoncontinues to build its heart business.Merck and Moderna Inc  ended 2023 with good news regarding their joint cancer vaccine and combined treatment that prevents recurrence and lowers the risk of the worst-case outcome in case of melanoma. Additionally on Tuesday, Moderna reported positive results of a small-sample trial of its experimental individualized cancer vaccine in combination with Merck-made Keytruda in treating those with head and neck cancers. Back in December, Merck and Moderna announced they will be expanding the tests of their combined treatment in combatting certain forms of lung cancer and initiated a Phase 3 trial. Back in February, Merck also revealed it expanded the clinic partnership with Adagene for","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9sf16v1Up_jmzHs3SJGVMQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/228fabdc2a5f989e7a5f233d875c8f90","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9sf16v1Up_jmzHs3SJGVMQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/228fabdc2a5f989e7a5f233d875c8f90"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharmaceutical-industry-finds-itself-historical-164751287.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426435518","title":"Mainz Biomed B.V. Confronts Escalating Cybersecurity Dangers Threatening Operations and Data Security","url":"https://stock-news.laohu8.com/highlight/detail?id=2426435518","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2426435518?lang=en_us&edition=fundamental","pubTime":"2024-04-10 14:00","pubTimestamp":1712728850,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has disclosed a new risk, in the Cyber Security category. Mainz Biomed B.V. faces significant cybersecurity threats that c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-b-v-confronts-escalating-cybersecurity-dangers-threatening-operations-and-data-security?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-b-v-confronts-escalating-cybersecurity-dangers-threatening-operations-and-data-security?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2418533078","title":"Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations","url":"https://stock-news.laohu8.com/highlight/detail?id=2418533078","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2418533078?lang=en_us&edition=fundamental","pubTime":"2024-03-12 12:01","pubTimestamp":1710216060,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif. and MAINZ, Germany, March  12, 2024  (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for ear","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/03/12/2844494/0/en/Mainz-Biomed-Presents-ColoAlert-at-UDH-Congress-2024-Leading-the-Way-in-Evidence-Based-Cancer-Screening-Innovations.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2417219757","title":"Analysts Are Bullish on Top Healthcare Stocks: Iterum Therapeutics (ITRM), Mainz Biomed B.V. (MYNZ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2417219757","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2417219757?lang=en_us&edition=fundamental","pubTime":"2024-03-07 00:30","pubTimestamp":1709742650,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Iterum Therapeutics (ITRM – Research Report) and Mai...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-iterum-therapeutics-itrm-mainz-biomed-b-v-mynz?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-iterum-therapeutics-itrm-mainz-biomed-b-v-mynz?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2417484417","title":"BRIEF-Mainz Biomed Partners With Trusted Health Advisors To Support US Go-To-Market Strategy For Next Generation Early Colorectal Cancer Diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2417484417","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2417484417?lang=en_us&edition=fundamental","pubTime":"2024-03-05 23:04","pubTimestamp":1709651072,"startTime":"0","endTime":"0","summary":"March 5 (Reuters) - Mainz Biomed NV   :   * MAINZ BIOMED NV - PARTNERS WITH TRUSTED HEALTH ADVISORS TO SUPPORT U.S. GO-TO-MARKET STRATEGY FOR NEXT GENERATION EARLY COLORECTAL CANCER DIAGNOSTICSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://mainzbiomed.com","stockEarnings":[{"period":"1week","weight":0.0302},{"period":"1month","weight":-0.2699},{"period":"3month","weight":-0.3268},{"period":"6month","weight":-0.4381},{"period":"1year","weight":-0.8685},{"period":"ytd","weight":-0.4139}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.","exchange":"NASDAQ","name":"Mainz Biomed B.V.","nameEN":"Mainz Biomed B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mainz Biomed B.V.(MYNZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mainz Biomed B.V.,MYNZ,Mainz Biomed B.V.股票,Mainz Biomed B.V.股票老虎,Mainz Biomed B.V.股票老虎国际,Mainz Biomed B.V.行情,Mainz Biomed B.V.股票行情,Mainz Biomed B.V.股价,Mainz Biomed B.V.股市,Mainz Biomed B.V.股票价格,Mainz Biomed B.V.股票交易,Mainz Biomed B.V.股票购买,Mainz Biomed B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mainz Biomed B.V.(MYNZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction